• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Strides Pharma Science Limited — Board Meeting, 31-07-2026: Outcome of Board Meeting

    31-07-2026 | 12:38 pm

    Strides Pharma Science's board approved Q1 financial results. Consolidated revenue hit ₹1,265.41 Cr, with profit at ₹156.91 Cr. EPS stood at ₹17.02. The board also proposed a ₹5/share final dividend and diluted its Pivot Path stake for ₹100 Cr, recording a ₹74.21 Cr gain.

    No comments yet. Be the first to comment!

    All announcements from Strides Pharma Science Limited